Sentences with phrase «aggressive lymphoma in»

Not exact matches

In clinical trials the treatment — which involves extracting individual patients» immune T - cells, modifying them to seek out tell - tale biological markers associated with blood cancers like aggressive lymphoma, and then pumping those modified killer cells back into the body — has shown major promise, in some cases eliminating all signs of the cancer in patients six months after treatmenIn clinical trials the treatment — which involves extracting individual patients» immune T - cells, modifying them to seek out tell - tale biological markers associated with blood cancers like aggressive lymphoma, and then pumping those modified killer cells back into the body — has shown major promise, in some cases eliminating all signs of the cancer in patients six months after treatmenin some cases eliminating all signs of the cancer in patients six months after treatmenin patients six months after treatment.

In December, Juno presented positive preliminary data on JCAR017 in patients with r / r aggressive non-Hodgkin lymphoma (NHL), reporting an 80 % overall response rate and a 60 % complete response ratIn December, Juno presented positive preliminary data on JCAR017 in patients with r / r aggressive non-Hodgkin lymphoma (NHL), reporting an 80 % overall response rate and a 60 % complete response ratin patients with r / r aggressive non-Hodgkin lymphoma (NHL), reporting an 80 % overall response rate and a 60 % complete response rate.

«This is wonderfully serendipitous — our drug just happens to be able to overcome both of the biological mechanisms that are key to survival of aggressive lymphoma,» Dr. Melnick says, adding that the inhibitor completely eradicated DLBCL in mice in a short time, with no detectable side effects.

In the journal Cell Reports, published today online, the scientists describe how the powerful master regulatory transcription factor Bcl6 regulates the genome, ensuring that aggressive lymphomas survive and thrive.

The most common type of non-Hodgkin lymphoma in adults, DLBCL is an aggressive cancer that can develop in many types of tissue.

Every year, nearly 2,000 people in Switzerland are diagnosed with lymphoma, a disease that can be very aggressive, resisting standard treatments with chemotherapeutic drugs.

Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes.

For example, a drug called ibrutinib has been tested in clinical trials to treat an aggressive form of non-Hodgkin lymphoma, diffuse large B - cell lymphoma (DLBCL).

This causes genomic instability in developing immune cells and, in the absence of a working tumor suppressor protein such as p53, an aggressive form of lymphoma develops in mice.

New research published online in Blood Journal of the American Society of Hematology (ASH), challenges the generally held belief that individuals with HIV and aggressive lymphoma are not candidates for standard treatment.

Scope: 22 institutions Treatment: CD19 - targeting CAR T - cell therapy Results: 42 % of patients with aggressive large B - cell lymphoma remained in remission after 15 months

Sixty percent of all NHL cases in the United States are aggressive NHL, with the most common subtype being diffuse large B - cell lymphoma (DLBCL).

The use of anti-CD19 chimeric antigen receptor T cells induced a nearly sixfold higher rate of complete response compared with historical outcomes in patients with refractory, aggressive non-Hodgkin lymphoma.

Surveillance computed tomography (CT) is usual practice for patients with aggressive non-Hodgkin lymphoma (aNHL) in complete remission (CR).

This is compared to Peripheral T cell lymphoma which is much more aggressive, seen in Boxers and Aussies.

Low - grade small cell lymphoma of the intestinal tract in cats is a less aggressive form of lymphoma.

Malignant Lymphoma This aggressive type of cancer occurs in the lymph nodes and can be fatal.

George Goldner and Nancy Krieg brought Nemo to Cornell's large animal hospital in 2013 for treatment of lymphoma, an aggressive blood cancer.